AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 151 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,000 | +92.9% | 1,817 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -22.2% | 1,817 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | +38.5% | 1,817 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -38.1% | 1,817 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -27.6% | 1,817 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -49.1% | 1,817 | -43.4% | 0.00% | – |
| Q1 2021 | $57,000 | +32.6% | 3,208 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | +13.2% | 3,208 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -19.1% | 3,208 | 0.0% | 0.00% | – |
| Q2 2020 | $47,000 | +6.8% | 3,208 | 0.0% | 0.00% | – |
| Q1 2020 | $44,000 | -42.9% | 3,208 | 0.0% | 0.00% | – |
| Q4 2019 | $77,000 | -56.7% | 3,208 | -46.9% | 0.00% | – |
| Q2 2019 | $178,000 | -32.6% | 6,046 | +8.4% | 0.00% | -100.0% |
| Q1 2019 | $264,000 | +82.1% | 5,575 | +34.0% | 0.00% | – |
| Q4 2018 | $145,000 | -43.4% | 4,160 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $256,000 | -8.9% | 4,160 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $281,000 | +24.3% | 4,160 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $226,000 | -8.9% | 4,160 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $248,000 | +21.6% | 4,160 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $204,000 | +54.5% | 4,160 | +65.0% | 0.00% | – |
| Q2 2017 | $132,000 | +15.8% | 2,521 | 0.0% | 0.00% | – |
| Q1 2017 | $114,000 | +18.8% | 2,521 | 0.0% | 0.00% | – |
| Q4 2016 | $96,000 | -74.6% | 2,521 | -74.9% | 0.00% | -100.0% |
| Q3 2016 | $378,000 | +2000.0% | 10,042 | +1616.6% | 0.00% | – |
| Q1 2015 | $18,000 | +38.5% | 585 | +33.0% | 0.00% | – |
| Q4 2014 | $13,000 | – | 440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|